Neu REFIX pre-clinical studies in mdx mice @ AOMC-JMS 2024
05 Oct 2024
Disease modifying approach in managing Duchenne Muscular Dystrophy with Neu REFIX Beta 1,3-1,6 Glucans was presented at the Joint Conference of The 22nd Annual Meeting of Asian and Oceanian Myology Center and The 10th Annual Meeting of Japan Muscle Society; 14, September 2024; Pre-clinical studies using mdx mice yielding reduction in inflammation and fibrosis and decline in fatigue explained; Available to watch in YouTube:
Clinical study results of Neu REFIX B-glucans & research updates by Dr. K. Raghavan 06 Oct 2024 Dr. Raghav
Neu REFIX pre-clinical studies in mdx mice @ AOMC-JMS 2024 05 Oct 2024 Disease modifying approach in managing
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm, Sweden 0
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE
At International Conference in Yokohama, Japan 17 Aug 2024 Nichi BRITE Beta glucan administration resulted in
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm, Sweden 0
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine (NCRM) have reported an increased yield of Beta 1,3-1,6 glucans in the produc
